Skip to content

Peptide · Metabolic

Tesamorelin

The stabilized GHRH analog studied specifically for the deep abdominal fat that resists diet and training.

Primary focusVisceral (deep abdominal) fat
Rx
AvailabilityProvider-reviewed · Telehealth
Check Eligibility

Available by consultation

Tesamorelin — MagsRX vial
MagsRX

What it is

Visceral Fat

Tesamorelin is a stabilized analog of growth-hormone-releasing hormone (GHRH), modified to resist the rapid enzymatic breakdown that limits native GHRH. Unlike broad "recovery" peptides, it is the GHRH analog most closely studied for its relationship to visceral adipose tissue — the metabolically active fat stored deep in the abdomen and around the organs, rather than the fat you can pinch. It works by prompting your own pituitary to release growth hormone in its natural rhythm, keeping your body's feedback loops in the driver's seat.

Studied for deep visceral fat, not just surface weight
Aims to support a leaner waistline and body composition
Designed to preserve your natural GH pulse and feedback
Studied alongside triglyceride and metabolic markers
How Tesamorelin works

Tesamorelin does not add growth hormone from the outside. It signals the pituitary to release your own — and its stabilized structure is designed to let that signal last long enough to be relevant to visceral fat.

Stage 01

A durable GHRH signal

Native GHRH degrades within minutes. Tesamorelin carries a stabilizing modification that resists that breakdown, so it can reach and activate GHRH receptors on the pituitary gland with a more sustained signal than the unmodified hormone.

Stage 02

A physiologic GH pulse

Rather than flooding the body with synthetic hormone, it is intended to prompt the pituitary to secrete growth hormone in the pulsatile, largely nighttime rhythm the body already uses — with a corresponding rise in circulating IGF-1 as a downstream result.

Stage 03

Mobilizing visceral fat

This restored GH/IGF-1 activity is thought to favor lipolysis in the deep abdominal (visceral) depot — the pathway that has made tesamorelin the GHRH analog of clinical interest for that particular fat store rather than surface tissue.

Candidacy

A considered fit, not a funnel.

Tesamorelin tends to interest adults who are already doing the work — eating well, training, sometimes already on a GLP-1 — yet still carry stubborn deep-belly fullness that the scale and mirror don't fully explain. It is a metabolic tool rather than a general wellness peptide, and it is prescribed only when a licensed provider judges it clinically appropriate for you.

Often a fit
  • Adults with disproportionate deep abdominal fullness despite diet and exercise
  • Those focused on metabolic and body-composition goals over sleep or recovery
  • People comfortable with a nightly self-injection routine sustained over months
Not appropriate if
  • Anyone pregnant, trying to conceive, or breastfeeding
  • A history of pituitary or hypothalamic tumor, or pituitary surgery/radiation
  • Active or recently treated malignancy, given GH/IGF-1's growth signaling

Expected Timeline

What to expect

Tesamorelin follows a steady nightly cadence and rewards patience — visceral fat is a slow-moving depot, and any meaningful change tends to accrue over months rather than weeks.

  1. 01

    Weeks 1-2

    Onboarding

    After provider review and baseline labs (often including IGF-1), you begin a nightly subcutaneous injection, timed to align with your body's natural overnight GH pulse. Early days are mostly about routine and tolerability.

  2. 02

    Weeks 3-8

    Adaptation

    The body settles into the restored GH rhythm. Some people notice steadier sleep or subtle body-composition shifts, while any visceral-fat effect is still building beneath the surface and not yet obvious on the scale.

  3. 03

    Months 3-6

    Visceral response

    This is the window in which deep-abdominal changes and waistline shifts more often become noticeable for those who respond. Your provider reassesses IGF-1 and overall response to decide on continuation, adjustment, or a maintenance approach.

Response varies by individual; not everyone responds the same way, and your provider may adjust dose, timing, or duration — or stop therapy — based on your labs and results.

The Science

Why clinicians reach for it.

Among the GH-axis peptides, tesamorelin carries the most specific body of research around one question: excess visceral adipose tissue.

01.

Centered on visceral fat

Research on tesamorelin has concentrated on the deep abdominal fat depot specifically — a distinction from GH secretagogues studied more broadly for lean mass, sleep, or recovery.

02.

Works through your own axis

Because it is designed to stimulate endogenous, pulsatile GH release rather than replace the hormone, it aims to raise GH/IGF-1 while respecting the hypothalamic-pituitary feedback that governs physiologic levels.

03.

Metabolic markers of interest

Beyond fat distribution, research attention has extended to related metabolic measures such as triglycerides — reflecting the broader connection between visceral fat and cardiometabolic health.

Our Standard of Care

Real transformation, with a friendly team that stands by you every step.

01.Provider-Supervised
Licensed providers review your health profile and guide every treatment decision. You only move forward when a plan is right for you.
02.Personalized Plans
GLP-1 and peptide protocols are titrated to your biology and your goals. No one-size-fits-all, no guesswork.
03.We Stand By You
From eligibility review to ongoing check-ins, our care team supports you throughout your transformation — discreet shipping and secure messaging included.

Clinical Safety

No therapy is right for everyone.

01

What to know

The most commonly reported effects are injection-site reactions (redness, itching, or swelling), joint aches and muscle pain, fluid retention or peripheral swelling, and occasional tingling or numbness in the hands. Because GH activity can affect glucose handling, blood sugar and insulin sensitivity may shift and are monitored, particularly in those with diabetes or prediabetes.

02

Contraindications

Tesamorelin is not appropriate during pregnancy, attempts to conceive, or breastfeeding, or for anyone with active malignancy or a disrupted hypothalamic-pituitary axis (pituitary or hypothalamic tumor, surgery, radiation, or trauma). Use caution with diabetes or diabetic retinopathy and with any history of hypersensitivity to tesamorelin or mannitol. Your provider will screen your history before prescribing.

Sourcing & Regulation — American Compounding

MagsRX protocols are prepared by partner compounding pharmacies in the United States. Compounding pharmacies are regulated by both state boards and the FDA and have been part of American medicine since long before mass-manufactured drugs existed. The active ingredient is prepared per your protocol — supervised by your provider — and delivered direct to your door.

Frequently Asked

Questions worth asking before you begin.

  • All three act on the GHRH pathway to stimulate your own growth hormone, but tesamorelin is the analog studied specifically in relation to visceral abdominal fat. Its stabilized structure resists breakdown, and its framing here is metabolic and body-composition focused rather than the sleep, recovery, or lean-mass emphasis often associated with the others.

  • Usually not. Visceral fat is a slow-responding depot, and for people who respond, noticeable changes more often emerge over roughly three to six months of consistent nightly use rather than in the first few weeks. Outcomes are not guaranteed.

  • No. It does not add growth hormone from outside the body — it is designed to signal your own pituitary to release GH in its natural rhythm, which is why the body's feedback loops stay involved. It is a compounded medication prescribed only if a licensed provider deems it appropriate for you.

Explore More

Other therapies to consider.

Begin

Tesamorelin begins with a short assessment.

A licensed provider reviews every order and prescribes only if it is clinically appropriate for you. Your therapy is prepared by a partner compounding pharmacy and delivered discreetly to your door.